Practical Aspects of Delivering Hereditary Cancer Risk Counseling

Seminars in Oncology

Volumn 34, Issue 5, 2007, Pages 369-378

  DeMarco, Tiffani A ^a   Smith, Karen L ^a,b   Nusbaum, Rachel H ^a   Peshkin, Beth N ^a   Schwartz, Marc D ^a   Isaacs, Claudine ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL PRACTICE; FAMILIAL CANCER; GENETIC COUNSELING; GENETIC DISORDER; HEALTH CARE AVAILABILITY; HIGH RISK PATIENT; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT COUNSELING; PRIORITY JOURNAL; RESOURCE MANAGEMENT; RISK ASSESSMENT; TELEMEDICINE; TELEPHONE;

GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC SERVICES; HUMANS; NEOPLASMS; PROFESSIONAL COMPETENCE; RISK ASSESSMENT; SOCIAL SUPPORT;

EID: 34848829776     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.07.003     Document Type: Article

References (60)

1. Trepanier A., Ahrens M., McKinnon W., et al. Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors. J Gene Counsel 13 (2004) 83-114
2. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 14 (1996) 1730-1736
3. American Society of Clinical Oncology: American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol 21 (2003) 2397-2406
4. American Gastroenterological Association: American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 121 (2001) 195-197
5. Shroy P.C., Barrison A.F., Ling B.S., et al. Family history and colorectal cancer screening: A survey of physicians knowledge and practice patterns. Am J Gastroenterol 97 (2002) 1031-1036
6. Culver J.O., Hull J.L., Dunne D.F.B., et al. Oncologists' opinions on genetic testing for breast and ovarian cancer. Genet Med 3 (2001) 120-125
7. Giardello F.M., Brensinger J.D., Petersen G.M., et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 336 (1997) 823-827
8. Alvarado M., Bars J., Carr A.G., et al. Cancer genetic counseling starter packet (2001). http://www.nsgc.org/members_only/tools/csp_disclaimer.cfm June, http://www.nsgc.org/members_only/tools/csp_disclaimer.cfm (accessed 11/30/2006)
9. Ho C. How to develop and implement a cancer genetics risk assessment service: Clinical and economic considerations. Oncol Iss Nov/Dec (2004) 22-26
10. DeMarco T.A., Loffredo C.A., Sampilo M.L., et al. On using a cancer center cancer registry to identify newly affected women eligible for hereditary breast cancer syndrome testing: Practical considerations. J Genet Counsel 15 (2006) 129-136
11. Affleck P. The challenge of recruitment. Nurs Res 13 (2005) 78-84
12. Roche C.A., Lucas M.R., and Hughes K.S. Development of a risk assessment clinic. In: Vogel V.G. (Ed). Management of Patients at High Risk for Breast Cancer (2001), Blackwell Science, Malden, MA 166-182
13. Peters J.A. Familial cancer risk: I. Impact on today's oncology practice. J Oncol Manage Sept-Oct (1994) 20-30
14. Oncology Nursing Society: The role of the oncology nurse in cancer genetic counseling: A position paper, 1997. Oncol Nurs Forum 25 (1998) 463
15. Oncology Nursing Society: Cancer genetic testing and risk assessment counseling: A position paper, 1997. Oncol Nurs Forum 25 (1998) 464
16. Lerman C., and Croyle R.T. Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 10 (1996) 191-199
17. Lerman C. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 15 (1994) 609-615
18. Pettersen B, Doyle DL, Cohen L, et al: Primer on Billing and Reimbursement, November 1, 2003. Available at http://www.nsgc.org/members_only/tools/br_index.cfm (accessed 11/28/2006)
19. National Society of Genetic Counselors. Billing and Reimbursement Toolkit. Available at http://www.nsgc.org/members_only/tools/br_index.cfm (accessed 11/30/2006)
20. Griffith A.G., Edwards R.T., Gray J., et al. Cancer genetics services: A systematic review of the economic evidence and issues. Br J Cancer 90 (2004) 1697-1703
21. Myriad Genetic Laboratories, Inc. Genetic testing for hereditary cancer syndromes: Billing for patient education. Available at http://www.myriadresourceguide.com/billing/billing.htm (accessed 11/21/2006)
22. Draft Report of the Secretary's Advisory Committee on Genetics, Health, and Society: Coverage and reimbursement of genetic tests and services. Public Comment Draft (2005) 1-54
23. American Medical Association. The Current Procedural Coding System. Available at http://www.ama-asn.org/ama/pub/category/3113.html (accessed 11/30/2006)
24. United States Department of Health and Human Services-Centers for Disease Control and Prevention. The International Classification of Diagnoses, Ninth Revision, Clinical Modification (ICD-9-CM). Available at http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm (accessed 11/30/2006)
25. Myriad Genetic Laboratories, Inc. Myriad reimbursement assistance service (MRAP). Available at http://www.myriadtests.com/mrap.htm (accessed 10/16/2006)
26. Myriad Genetic Laboratories, Inc: External Price List (4/15/06). Available upon request at info @myriad.com
27. City of Hope National Medical Center: Clinical molecular diagnosis laboratory. Available at http://www.cityof hope.org/cmdl/ (accessed 11/28/2006)
28. Myriad Genetic Laboratories, Inc. Available at www.myriad.com (accessed 11/27/2006)
29. Shappel H.L., and Matloff E.T. Writing effective insurance justification letters for cancer genetic testing: a streamlined approach. J Genet Counsel 10 (2001) 331-341
30. Myriad Genetic Laboratories, Inc. Sample LMNs. Available at http://www.myriadtests.com/provider/doc/lmn.brac.doc (accessed 11/30/2006)
31. Centers for Medicare and Medicaid Services. Medicare Coverage Database. Available at http://www.cms.hhs.gov/mcd/viewlcd.asp?lcd_id=9741&lcd_version=13&show=all (accessed 11/30/2006)
32. Centers for Medicare and Medicaid Services. Available at http://www.cms.hhs.gov/home/medicaid.asp (accessed 11/30/2006)
33. Financial Hardship Assistance Packet (PDF format). Available upon request from info @ myriad.com (accessed 11/30/2006)
34. Lindor N.M., and Greene M.H. The concise handbook of familial cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 90 (1998) 1039-1071
35. Schneider K., and Garber J. Counseling About Cancer: Strategies for Genetic Counselor. (ed 2) (2001), Wiley, New York, NY
36. Gail M.H., Brinton L.A., Byar D.B., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 (1989) 1879-1886
37. Offit K., and Brown K. Quantitating familial cancer risk: A resource for clinical oncologists. J Clin Oncol 12 (1994) 1724-1736
38. CancerGene. Available at http://www4.southwestern.edu/breasthealth/cagene/default.asp (accessed 11/30/2006)
39. Kang H.H., Williams R., Leary J., et al. Evaluation of models to predict BRCA germline mutations. Br J Cancer 95 (2006) 914-920
40. Offit K., Groeger E., Turner S., et al. The "duty to warn" a patient's family members about hereditary disease risks. JAMA 292 (2004) 1469-1473
41. Peshkin B.A., DeMarco T.A., Brogan B.M., et al. BRCA1/2 testing: Complex themes in result interpretation. J Clin Oncol 19 (2001) 2555-2565
42. DeMarco T.A., Peshkin B.N., and Brogan B.B. Across the spectrum: cases studies in genetic counseling for breast and ovarian cancer susceptibility. J Genet Counsel 10 (2001) 379-395
43. National Human Genome Research Institute: Genetic discrimination. Available at http://www.genome.gov/10002077#2 (accessed 11/27/2006)
44. Georgetown University Health Policy Institute: Consumer guides for getting and keeping health insurance. Available at http://www.healthinsuranceinfo.net (accessed 11/30/2006)
45. Harris M., Winship I., and Spriggs M. Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 6 (2005) 301-310
46. Council on Ethical and Judicial Affairs of the American Medical Association, Opinion E-2.131: Disclosure of familial risk in genetic testing: American Medical Association, code of medical ethics. Available at: http://www.ama-assn.org/apps/pf_new/pf_online?f_n=resultLink&doc=policyfiles/HnE/E-2.131.HTM&s_t=familial+risk&catg=AMA/HnE&catg=AMA/BnGnC&catg=AMA/DIR&&nth=1&&st_p=0&nth=1& (accessed November 27, 2006)
47. Knoppers B., Strom C., Clayton E., et al. Professional disclosure of familial genetic information. Am J Hum Genet 62 (1998) 474-483
48. Mitchell J.A., and Demiris G. Telegenetics: The next phase in the provision of genetic services?. Genet Med 7 (2005) 1-2
49. Coelho J.J., Arnold A., Nayler J., et al. An assessment of the efficacy of cancer genetic counseling using real-time videoconferencing technology (telemedicine) compared to face-to-face consultations. Eur J Cancer 41 (2005) 2257-2261
50. Ormond K.E., Haun J., Cook L., et al. Recommendations for telephone counseling. J Genet Counsel 9 (2000) 63-71
51. Wang V.O. Commentary: What is and is not telephone counseling?. J Genet Counsel 9 (2000) 73-82
52. Sangha K.K., Dircks A., and Laglois S. Assessment of the effectiveness of genetic counseling by telephone compared to a clinic visit. J Genet Counsel 13 (2003) 171-184
53. National Institutes of Health, Clinical Trials. Telephone-based genetic counseling or standard genetic counseling in women at risk of carrying the BRCA1 or BRCA2 mutation-Identifier-NCT00287898. Available at http://www.clinicaltrials.gov (accessed 10/13/2006)
54. Wolfberg A.J. Genes on the web: Direct to consumer marketing of genetic testing. N Engl J Med 355 (2006) 543-545
55. DNA direct. http://www.dnadirect.com (accessed 10/13/2006)
56. Gray S., and Olopode O.I. Direct to consumer marketing of genetic tests for cancer: Buyer beware. J Clin Oncol 21 (2003) 3191-3193
57. Gollust S.E., Wilfond B.S., and Hill S.C. Direct-to-consumer sales of genetic services on the internet. Genet Med 5 (2003) 332-337
58. Green M.J., Peterson S.K., Baker M.W., et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA 292 (2004) 442-452
59. Kaufman E.M., Peshkin B.N., Lawrence W.F., et al. Development of an interactive decision aid for female BRCA1/BRCA2 carriers. J Genet Counsel 12 (2003) 109-129
60. Epplein M., Koon K.P., Ramsey S.D., et al. Genetic services for familial cancer patients: A follow-up survey of national cancer institute cancer centers. J Clin Oncol 23 (2005) 4713-4718